Oral semaglutides efficacy in trials (PIONEER program) was similar to weekly injection: A1c reductions ~1.01.4% with 14 mg daily, weight loss ~34 kg ( [135] )
6,7 Importantly, Berberine may interact adversely with hypoglycemic medications, potentially causing excessive lowering of blood glucose levels, and it can also interact with antibiotics
The primary benefit is awareness
In human dental pulp stem cells (hDPSC), the expression of the osteogenic markers RUNX2 , COL1 , osteonectin, and osteocalcin was upregulated via the LINC00968/miR-3658 axis [27]
Phase 3 data from the TRIUMPH-4 trial showed an average of 28.7% body weight reduction at the 12 mg dose over 68 weeks
Other possible mechanisms include antiinflammatory, antifibrotic, antiatherosclerotic, vasodilatory, and other hemodynamic effects [30]